Second harmonic imaging nanoprobes and techniques for use thereof

Patent metadata

Field	Value
Publication number	US-9476830-B2
Application number	US-94426407-A
Country	US
Kind code	B2
Filing date	Nov 21, 2007
Priority date	Nov 21, 2006
Publication date	Oct 25, 2016
Grant date	Oct 25, 2016

Abstract

Second harmonic nanoprobes for imaging biological samples and a method of using such probes to monitor the dynamics of biological process using a field resonance enhanced second harmonic (FRESH) technique are provided. The second harmonic generating (SHG) nanoprobes are comprised of various kinds of nanocrystals that do not possess an inversion symmetry and therefore are capable of generating second harmonic signals that can then be detected by conventional two-photon microscopy for in vivo imaging of biological processes and structures such as cell signaling, neuroimaging, protein conformation probing, DNA conformation probing, gene transcription, virus infection and replication in cells, protein dynamics, tumor imaging and cancer therapy evaluation and diagnosis as well as quantification in optical imaging.

First claim

What is claimed is:

1. A second harmonic generating nanoprobe imager comprising:
at least one nanocrystal nanoprobe formed of a crystal material being associated with at least one biological target, the crystal material having a unit cell with no inversion symmetry such that the crystal material generates a second harmonic emission when radiated by an external excitation source;
an external excitation source for radiating the nanocrystal nanoprobe at a frequency such that the crystal material of the nanocrystal nanoprobe generates a second harmonic emission; and
a detector configured to collect a signal from the second harmonic emission, the signal identifying at least one biological target; and
wherein the at least one nanocrystal nanoprobe generates the second harmonic emission regardless of the attachment and orientation of the nanocrystal nanoprobe to the at least one biological target.

2. The second harmonic nanoprobe imager of claim 1 , wherein the crystal material is selected from the group consisting of organic, inorganic and combinations thereof.

3. The second harmonic nanoprobe imager of claim 2 , wherein the crystal material is selected from the group consisting of BaTiO 3 , SiC, ZnO, ZnS, ZnSe, ZnTe, CdS, CdSe, CdTe, GaAs, GaSb, GaP, GaN, InSb, LiNbO 3 , KNbO 3 , KTiOPO 4 , Fe(IO 3 ) 3 , N-(4-nitrophenyl)-(L)-prolinol, urea, 4-Nitroaniline, 2-Methyl-4-nitroaniline, 3-Methyl-4-methoxy-4′-nitrostilbene, β-BaB 2 O4, LiB 3 O 5 , LiNbO 3 , KTiOPO4, AgGaS 2 , AgGaSe 2 , ZnGeP 2 , GaSe, KH 2 PO 4 , NH 4 H 2 PO 4 , KD 2 PO 4 , CsLiB 6 O 10 , KTiOAsO 4 , KNbO 3 , LiTaO 3 , RbTiOAsO 4 , BaTiO 3 , MgBaF 4 , GaAs, BiB 3 O 6 , K 2 Al 2 B 2 O 7 , KBe 2 BO 3 F 2 , BaAlBO 3 F 2 , La 2 CaB 10 O 19 , GdCa 4 O(BO 3 ) 3 , YCa 4 O(BO 3 ) 3 , Li 2 B 4 O 7 , LiRbB 4 O 7 , CdHg(SCN) 4 , RbTiOPO 4 , LiInS 2 , LiInSe 2 , KB 5 O 8 .4H 2 O, CsB 3 O 5 , C 4 H 7 D 12 N 4 PO 7 , a-HIO 3 , LiCOOH.H 2 O, CsH 2 AsO 4 , CsD 2 AsO 4 , RbH 2 PO 4 , CsTiOAsO 4 , Ba 2 NaNb 5 O 15 , K 3 Li 2 Nb 5 O 15 , CO(NH 2 ) 2 , LiIO 3 , Ag 3 AsS 3 , HgGa 2 S 4 , CdGeAs 2 , Ti 3 AsSe 3 , CdSe, ZnO, ZnS, ZnSe, ZnTe, CdS, SiC, GaN, and GaSb.

4. The second harmonic nanoprobe imager of claim 1 , wherein the nanocrystal nanoprobe is less than or equal to 10 μm.

5. The second harmonic nanoprobe imager of claim 1 , wherein the excitation source is selected from the group consisting of continuous wave, modulated and pulsed lasers.

6. A field resonance enhanced second harmonic nanoprobe imager comprising:
an exciter nanostructure, said exciter nanostructure designed to produce an enhanced local electrical field of a specified frequency when exposed to an excitation source, wherein the exciter nanostructure is attached to a first biological target of interest;
at least one nanocrystal nanoprobe formed of a crystal material attached to a second biological target of interest, the crystal material having a unit cell with no inversion symmetry such that the crystal material of the nanocrystal nanoprobe generates a second harmonic resonance emission when brought within a resonance range of the resonant electrical field of said exciter nanostructure on said first biological target of interest;
wherein the first and second biological targets are movable relative to one another such that the exciter nanostructure and at least one nanocrystal may dynamically shift into and out of resonance range;
an external excitation source for radiating the exciter nanostructure at a frequency such that the exciter nanostructure generates the enhanced electrical field of said specified frequency; and
a detector configured to collect a signal from the second harmonic emission, the signal identifying when the first and second biological targets are within said resonance range; and
wherein the at least one nanocrystal nanoprobe generates the second harmonic emission regardless of the attachment and orientation of the nanocrystal nanoprobe to the at least one biological target.

7. The field resonance enhanced second harmonic nanoprobe imager of claim 6 , wherein the exciter nanostructure is a metal nanostructure.

8. The field resonance enhanced second harmonic nanoprobe imager of claim 7 , wherein the metal nanostructure is a nanostructure selected from the group consisting of nanorods, nanospheres or nanoshells.

9. The field resonance enhanced second harmonic nanoprobe imager of claim 8 , wherein the metal nanostructure is made of gold, silver, copper, aluminum, palladium, or platinum.

10. The field resonance enhanced second harmonic nanoprobe imager of claim 6 , wherein the crystal material is selected from the group consisting of organic, inorganic and combinations thereof.

11. The field resonance enhanced second harmonic nanoprobe imager of claim 10 , wherein the crystal material is selected from the group consisting of BaTiO 3 , SiC, ZnO, ZnS, ZnSe, ZnTe, CdS, CdSe, CdTe, GaAs, GaSb, GaP, GaN, InSb, LiNbO 3 , KNbO 3 , KTiOPO 4 , Fe(IO 3 ) 3 , N-(4-nitrophenyl)-(L)-prolinol, urea, 4-Nitroaniline, 2-Methyl-4-nitroaniline, 3-Methyl-4-methoxy-4′-nitrostilbene, β-BaB 2 O4, LiB 3 O 5 , LiNbO 3 , KTiOPO4, AgGaS 2 , AgGaSe 2 , ZnGeP 2 , GaSe, KH 2 PO 4 , NH 4 H 2 PO 4 , KD 2 PO 4 , CsLiB 6 O 10 , KTiOAsO 4 , KNbO 3 , LiTaO 3 , RbTiOAsO 4 , BaTiO 3 , MgBaF 4 , GaAs, BiB 3 O 6 , K 2 Al 2 B 2 O 7 , KBe 2 BO 3 F 2 , BaAlBO 3 F 2 , La 2 CaB 10 O 19 , GdCa 4 O(BO 3 ) 3 , YCa 4 O(BO 3 ) 3 , Li 2 B 4 O 7 , LiRbB 4 O 7 , CdHg(SCN) 4 , RbTiOPO 4 , LiInS 2 , LiInSe 2 , KB 5 O 8 .4H 2 O, CsB 3 O 5 , C 4 H 7 D 12 N 4 PO 7 , a-HIO 3 , LiCOOH.H 2 O, CsH 2 AsO 4 , CsD 2 AsO 4 , RbH 2 PO 4 , CsTiOAsO 4 , Ba 2 NaNb 5 O 15 , K 3 Li 2 Nb 5 O 15 , CO(NH 2 ) 2 , LiIO 3 , Ag 3 AsS 3 , HgGa 2 S 4 , CdGeAs 2 , Ti 3 AsSe 3 , CdSe, ZnO, ZnS, ZnSe, ZnTe, CdS, SiC, GaN, and GaSb.

12. The field resonance enhanced second harmonic nanoprobe imager of claim 6 , wherein the nanocrystal nanoprobe is less than or equal to 10 μm.

13. The field resonance enhanced second harmonic nanoprobe imager of claim 6 , wherein the nanocrystal nanoprobe and the exciter nanostructure are both attached to different spatially separated portions of a single target of interest.

14. The field resonance enhanced second harmonic nanoprobe imager of claim 6 , wherein the excitation source is selected from the group consisting of continuous wave, modulated and pulsed lasers.

Assignees

• Pantazis Periklis
• Pu Ye
• Psaltis Demetri
• Hong John H
• Fraser Scott E
• California Inst Of Techn

Inventors

• Pantazis Periklis
• Pu Ye
• Psaltis Demetri
• Hong John H
• Fraser Scott E

Classifications

• G02F1/37

  for second-harmonic generation {(G02F1/3532 takes precedence)} · CPC title

• B82Y20/00

  Nanooptics, e.g. quantum optics or photonic crystals · CPC title

• G01N21/636 Primary

  using an arrangement of pump beam and probe beam; using the measurement of optical non-linear properties; (non-linear optics per se G02F1/35) · CPC title

• B82Y15/00

  Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors · CPC title

• A61K49/0002

  General or multifunctional contrast agents, e.g. chelated agents · CPC title